N-(6-methoxybenzo[d]thiazole-2-yl)-2-(3-oxo-3H-benzo[f]chromen-1-yl)acetamide | 1312806-21-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 萘并吡喃类
• 英文名称: N-(6-methoxybenzo[d]thiazole-2-yl)-2-(3-oxo-3H-benzo[f]chromen-1-yl)acetamide
• 英文别名: N-(6-methoxy-1,3-benzothiazol-2-yl)-2-(3-oxobenzo[f]chromen-1-yl)acetamide
• CAS: 1312806-21-5
• 化学式: C₂₃H₁₆N₂O₄S
• 分子量: 416.457
• InChiKey: CDKKGSSZRRHAOZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  30
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  106
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  3-氧代-3H-萘并[1,2-b]吡喃-1-乙酸 在 吡啶 、 氯化亚砜 作用下， 以 四氢呋喃 为溶剂， 生成 N-(6-methoxybenzo[d]thiazole-2-yl)-2-(3-oxo-3H-benzo[f]chromen-1-yl)acetamide
  参考文献：
  名称：

  Synthesis and in vitro anti-HIV activity of N-1,3-benzo[d]thiazol-2-yl-2-(2-oxo-2H-chromen-4-yl)acetamide derivatives using MTT method

  摘要：

  A series of novel N-1,3-benzo[d]thiazol-2-yl-2-(2-oxo-2H-chromen-4-yl)acetamide derivatives has been synthesized. All the newly synthesized compounds were evaluated for their anti-HIV activity using MTT method. Most of these compounds showed moderate to potent activity against wild-type HIV-1 with an EC50 ranging from >7 EC50 [mu g/ml] to <100 EC50 [mu g/ml]. Among them, N-1,3-benzo[d]thiazol-2-yl-2-(2-oxo-2H-chromen-4-yl)acetamide 6v was identified as the most promising compound (EC50 = <7 mu g/ml). Among all the compounds, three compounds 6m, 6v and 6u have been exhibits potent anti-HIV activity against MT-4 cells. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.03.105

文献信息

• Synthesis and in vitro anti-HIV activity of N-1,3-benzo[d]thiazol-2-yl-2-(2-oxo-2H-chromen-4-yl)acetamide derivatives using MTT method
  作者：Dhairya Bhavsar、Jalpa Trivedi、Shrey Parekh、Mahesh Savant、Shailesh Thakrar、Abhay Bavishi、Ashish Radadiya、Hardevsinh Vala、Jignesh Lunagariya、Manisha Parmar、Ladwa Paresh、Roberta Loddo、Anamik Shah

  DOI：10.1016/j.bmcl.2011.03.105

  日期：2011.6

  A series of novel N-1,3-benzo[d]thiazol-2-yl-2-(2-oxo-2H-chromen-4-yl)acetamide derivatives has been synthesized. All the newly synthesized compounds were evaluated for their anti-HIV activity using MTT method. Most of these compounds showed moderate to potent activity against wild-type HIV-1 with an EC50 ranging from >7 EC50 [mu g/ml] to <100 EC50 [mu g/ml]. Among them, N-1,3-benzo[d]thiazol-2-yl-2-(2-oxo-2H-chromen-4-yl)acetamide 6v was identified as the most promising compound (EC50 = <7 mu g/ml). Among all the compounds, three compounds 6m, 6v and 6u have been exhibits potent anti-HIV activity against MT-4 cells. (C) 2011 Elsevier Ltd. All rights reserved.